Valuation: ConvaTec Group

Market Cap 573.58Cr 501.19Cr 460.23Cr 429.2Cr 813.66Cr 55TCr 827.39Cr 5.54TCr 2.15TCr 27TCr 2.15TCr 2.11TCr 92TCr P/E 2026 *
20.8x
P/E 2027 * 16.3x
Enterprise Value 693.55Cr 606.02Cr 556.49Cr 518.97Cr 983.84Cr 66TCr 1TCr 6.7TCr 2.6TCr 32TCr 2.6TCr 2.55TCr 1,11600Cr EV / Sales 2026 *
2.7x
EV / Sales 2027 * 2.47x
Free-Float
95.19%
Yield 2026 *
2.67%
Yield 2027 * 2.99%
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 573.58Cr
+3.49%+2.32%-28.86%-12.49% 17TCr
+5.04%+3.32%-5.77%-5.57% 11TCr
+2.80%+3.33%+1.83%+54.09% 5.77TCr
+2.01%+2.07%+54.19%+50.85% 5.32TCr
+3.39%+4.43%-10.83%-40.12% 4.36TCr
+3.50%+14.35% - - 3.65TCr
+3.47%+3.79%-14.75%-44.56% 2.75TCr
+0.20%+5.53%+65.33%-4.37% 2.58TCr
+2.78%+3.61%-8.42%-3.01% 2.13TCr
Average +2.67%+4.14%+6.59%-0.65% 5.98TCr
Weighted average by Cap. +3.35%+3.29%-3.57%+0.01%

Financials

2026 *2027 *
Net sales 256.63Cr 224.24Cr 205.92Cr 192.03Cr 364.04Cr 24TCr 370.19Cr 2.48TCr 960.84Cr 12TCr 963.59Cr 942.65Cr 41TCr 273.76Cr 239.21Cr 219.66Cr 204.85Cr 388.34Cr 26TCr 394.89Cr 2.64TCr 1.02TCr 13TCr 1.03TCr 1.01TCr 44TCr
Net income 28Cr 24Cr 22Cr 21Cr 39Cr 2.63TCr 40Cr 266.95Cr 103.46Cr 1.29TCr 103.75Cr 101.5Cr 4.45TCr 36Cr 31Cr 29Cr 27Cr 51Cr 3.42TCr 52Cr 347.23Cr 134.57Cr 1.68TCr 134.95Cr 132.02Cr 5.78TCr
Net Debt 119.97Cr 104.83Cr 96Cr 90Cr 170.18Cr 11TCr 173.05Cr 1.16TCr 449.16Cr 5.6TCr 450.45Cr 440.66Cr 19TCr 103.4Cr 90Cr 83Cr 77Cr 146.68Cr 9.84TCr 149.15Cr 998.94Cr 387.14Cr 4.83TCr 388.24Cr 379.8Cr 17TCr
Logo ConvaTec Group
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA